Osteoarthritis
- PMID: 31034380
- DOI: 10.1016/S0140-6736(19)30417-9
Osteoarthritis
Abstract
Osteoarthritis is a leading cause of disability and source of societal cost in older adults. With an ageing and increasingly obese population, this syndrome is becoming even more prevalent than in previous decades. In recent years, we have gained important insights into the cause and pathogenesis of pain in osteoarthritis. The diagnosis of osteoarthritis is clinically based despite the widespread overuse of imaging methods. Management should be tailored to the presenting individual and focus on core treatments, including self-management and education, exercise, and weight loss as relevant. Surgery should be reserved for those that have not responded appropriately to less invasive methods. Prevention and disease modification are areas being targeted by various research endeavours, which have indicated great potential thus far. This narrative Seminar provides an update on the pathogenesis, diagnosis, management, and future research on osteoarthritis for a clinical audience.
Copyright © 2019 Elsevier Ltd. All rights reserved.
Similar articles
-
Hip and Knee Osteoarthritis Affects Younger People, Too.J Orthop Sports Phys Ther. 2017 Feb;47(2):67-79. doi: 10.2519/jospt.2017.7286. J Orthop Sports Phys Ther. 2017. PMID: 28142365
-
Osteoarthritis.Clin Evid. 2002 Jun;(7):1071-90. Clin Evid. 2002. Update in: Clin Evid. 2002 Dec;(8):1212-37.. PMID: 12230728 Updated. Review. No abstract available.
-
Osteoarthritis.Clin Evid. 2002 Dec;(8):1212-37. Clin Evid. 2002. Update in: Clin Evid. 2003 Dec;(10):1402-30.. PMID: 12603937 Updated. Review. No abstract available.
-
What is the selection process for osteoarthritis pharmacotherapy?Expert Opin Pharmacother. 2020 Aug;21(12):1393-1397. doi: 10.1080/14656566.2020.1761325. Epub 2020 Apr 30. Expert Opin Pharmacother. 2020. PMID: 32352847
-
[Osteoarthritis].Tidsskr Nor Laegeforen. 2010 Nov 4;130(21):2136-40. doi: 10.4045/tidsskr.09.1054. Tidsskr Nor Laegeforen. 2010. PMID: 21052117 Review. Norwegian.
Cited by
-
Ferroptosis in Osteoarthritis: Current Understanding.J Inflamm Res. 2024 Nov 7;17:8471-8486. doi: 10.2147/JIR.S493001. eCollection 2024. J Inflamm Res. 2024. PMID: 39529997 Free PMC article. Review.
-
Antioxidant hydrogels for the treatment of osteoarthritis: mechanisms and recent advances.Front Pharmacol. 2024 Oct 25;15:1488036. doi: 10.3389/fphar.2024.1488036. eCollection 2024. Front Pharmacol. 2024. PMID: 39525636 Free PMC article. Review.
-
IHH-GLI-1-HIF-2α signalling influences hypertrophic chondrocytes to exacerbate osteoarthritis progression.J Orthop Translat. 2024 Oct 22;49:207-217. doi: 10.1016/j.jot.2024.09.008. eCollection 2024 Nov. J Orthop Translat. 2024. PMID: 39498143 Free PMC article.
-
Approach to the patient with controlled acromegaly and acromegalic arthropathy: clinical diagnosis and management.Pituitary. 2024 Nov 1. doi: 10.1007/s11102-024-01465-1. Online ahead of print. Pituitary. 2024. PMID: 39485592 Review.
-
Targeting ROS in osteoclasts within the OA environment: A novel therapeutic strategy for osteoarthritis management.J Tissue Eng. 2024 Sep 24;15:20417314241279935. doi: 10.1177/20417314241279935. eCollection 2024 Jan-Dec. J Tissue Eng. 2024. PMID: 39483974 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
